In this episode of the Not Just NE Cancer podcast, Cathy speaks to Ruth, the incredible fundraiser and founder behind 'Daily Dip 4 Dave'.

Since October 2023, Ruth has taken a cold-water dip every single day, inspired by her husband, Dave, who is living with neuroendocrine cancer.

Through stormy weather, freezing temperatures and exhaustion, she’s stayed committed, raising awareness and vital funds for Neuroendocrine Cancer UK, one freezing plunge at a time.

This October marks 2 years and to celebrate, we’re making a splash.

Join us on Saturday 11th October 2025 for the National Daily Dip 4 Dave Day.
One day. Hundreds of dips. Wherever you are, however you do it, just dip!

For Ruth. For Dave. For everyone affected by neuroendocrine cancer.

If you haven't already heard of Ruth and Dave's story, this episode shines a light on why 'Daily Dip 4 Dave' started, including Ruth's most memorable dips!

To be part of this incredible movement, please visit the Daily Dip 4 Dave page on our website: HERE

Support the show

In this heartfelt and deeply personal episode, Neuroendocrine Cancer UK’s CEO, Cathy, interviews Kate Quirk and Craig Speirs. Both are not only professionals working for Neuroendocrine Cancer UK but are also living with neuroendocrine cancer themselves, thus offering rare dual perspectives on navigating cancer both personally and professionally. Kate works as our Neuroendocrine Cancer Support Co-ordinator and Craig as our Fundraising Co-ordinator.

Their conversation includes:

• Personal Journeys
• Perspective and Purpose
• Professional Roles at NCUK
• Bridging the Gap - working in cancer support while also being patients
• Barriers and Bugbears
• The Power of Support - inc. the significance of language
• Closing Reflections

To learn more about neuroendocrine cancer, please visit out website: www.neuroendocrinecancer.org.uk

Please Support the show

Support the show

🎙️ In this episode of the Not Just NE Cancer podcast, Neuroendocrine Cancer UK CEO and Co-Founder, Cathy Bouvier Ellis sits down with Tanya Hills, Global Patient Engagement Lead at Boehringer Ingelheim.

Together, they explore:

• Common misconceptions about the pharmaceutical industry
• How patient organisations and the industry can work collaboratively
• How effective these collaborations can be

Tanya also highlights a current clinical trial led by Boehringer Ingelheim for Extrapulmonary Neuroendocrine Carcinoma (EP-NEC). You can find more information about this trial here:

🔗 Boehringer Ingelheim – EP-NEC Clinical Trial

To learn more about ongoing neuroendocrine cancer research, visit our website:
🔗 Neuroendocrine Cancer UK – Research

Support the show